Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China · Delayed Price · Currency is CNY 24.49
-0.81 (-3.20%)
Apr 28, 2026, 3:04 PM CST
SHE:002773 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 1,070 | 1,163 | 1,191 | 1,045 | 896.67 | 421.08 |
Depreciation & Amortization | 238.14 | 238.14 | 230.41 | 222.6 | 158.27 | 149.38 |
Other Amortization | 5.79 | 5.79 | 3.98 | 3.72 | 4.57 | 2.44 |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | -0.01 | -0.01 | - | - |
Asset Writedown & Restructuring Costs | 6.19 | 6.19 | 1.14 | 1.35 | 0.68 | 215.06 |
Loss (Gain) From Sale of Investments | -36.24 | -36.24 | -47.28 | -45.03 | -38.06 | -26.43 |
Stock-Based Compensation | -0.55 | -0.55 | 1.06 | - | - | - |
Provision & Write-off of Bad Debts | 0.36 | 0.36 | 0.39 | 0.24 | -0.4 | -2.64 |
Other Operating Activities | -11.26 | -15.02 | -12.16 | -11.9 | -27.74 | 0.97 |
Change in Accounts Receivable | -3.01 | -3.01 | -45.75 | -5.82 | 16.12 | 151.98 |
Change in Inventory | -22.16 | -22.16 | 13.79 | -65.01 | -38.46 | -57.03 |
Change in Accounts Payable | 37.99 | 37.99 | -30.38 | -61.36 | -116.71 | -249.47 |
Change in Other Net Operating Assets | 2.05 | 2.05 | 1.75 | 3.82 | 7.79 | 4.71 |
Operating Cash Flow | 1,415 | 1,504 | 1,412 | 1,218 | 925.15 | 494.11 |
Operating Cash Flow Growth | -1.68% | 6.50% | 15.88% | 31.70% | 87.23% | 80.78% |
Capital Expenditures | -284.76 | -262.48 | -159.39 | -138.87 | -355.21 | -569.42 |
Sale of Property, Plant & Equipment | 0.22 | 0.21 | 0.55 | 0.2 | 0.06 | 0.08 |
Investment in Securities | 2,200 | - | - | 100 | 100 | -251.85 |
Other Investing Activities | 36.6 | 36.9 | 46.79 | 45.29 | 39.6 | 18.06 |
Investing Cash Flow | 1,952 | -225.37 | -112.06 | 6.62 | -215.55 | -803.14 |
Long-Term Debt Repaid | - | -1.92 | -1.49 | -1.99 | -2.6 | -2.13 |
Total Debt Repaid | -1.92 | -1.92 | -1.49 | -1.99 | -2.6 | -2.13 |
Net Debt Issued (Repaid) | -1.92 | -1.92 | -1.49 | -1.99 | -2.6 | -2.13 |
Issuance of Common Stock | 33.24 | 33.24 | 6.75 | - | - | - |
Common Dividends Paid | -552.67 | -552.67 | -349.4 | -137.92 | -91.95 | -91.95 |
Other Financing Activities | 1.77 | 1.83 | - | 9.41 | 20.7 | 15.24 |
Financing Cash Flow | -519.58 | -519.52 | -344.14 | -130.5 | -73.85 | -78.84 |
Foreign Exchange Rate Adjustments | -0.27 | -0.48 | -0.25 | -0.21 | 0.99 | -0.87 |
Net Cash Flow | 2,847 | 758.28 | 955.43 | 1,094 | 636.74 | -388.73 |
Free Cash Flow | 1,130 | 1,241 | 1,252 | 1,080 | 569.95 | -75.3 |
Free Cash Flow Growth | -12.01% | -0.90% | 16.02% | 89.41% | - | - |
Free Cash Flow Margin | 25.49% | 27.07% | 28.13% | 27.28% | 16.82% | -2.09% |
Free Cash Flow Per Share | 1.22 | 1.34 | 1.37 | 1.18 | 0.62 | -0.08 |
Cash Income Tax Paid | 473.77 | 434.85 | 400.54 | 391.52 | 343.76 | 450.78 |
Levered Free Cash Flow | 579.96 | 668.82 | 851.56 | 681.33 | 398.96 | -399.12 |
Unlevered Free Cash Flow | 579.96 | 668.82 | 851.56 | 681.33 | 398.96 | -399.12 |
Change in Working Capital | 142.03 | 142.03 | 43.12 | 2.66 | -68.84 | -265.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.